Collegium Pharmaceutical (COLL) Gets a Buy Rating from Needham

In a report released today, Serge Belanger from Needham assigned a Buy rating to Collegium Pharmaceutical (COLL – Research Report), with a price target of $34.00. The company's shares closed last Thursday at $22.29. According to TipRanks.com, Belanger is a 4-star analyst with an average return of 6.8% and a 47.2% success rate. Belanger covers the Healthcare sector, focusing on stocks such as Amphastar Pharmaceuticals, KalVista Pharmaceuticals, and Verrica Pharmaceuticals. Collegium Pharmaceutical has an analyst consensus of Strong Buy, with a price target consensus of $35.67. See today’s analyst top recommended stocks >> Collegium Pharmaceutical's market cap is currently $785.7M and has a P/E ratio of 19.60. The company has a Price to Book ratio of 4.71. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities. Collegium Pharmaceutical, Inc. operates as a pharmaceutical company, which engages in the developing and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR. The Xtampza ER provides pain control while maintaining its extended-release drug release profile after being subjected to common methods of abuse and accidental misuse. The Nucynta ER for the treatment of chronic pain and neuropathic pain associated with diabetic peripheral neuropathy. The Nucynta IR is a release formulation of tapentadol indicated for the management of acute pain severe enough to require an opioid analgesic. The company was founded by Michael Thomas Heffernan in October 2003 and is headquartered in Stoughton, MA. The post Collegium Pharmaceutical (COLL) Gets a Buy Rating from Needham appeared first on TipRanks Financial Blog.

In a report released today, Serge Belanger from Needham assigned a Buy rating to Collegium Pharmaceutical (COLL – Research Report), with a price target of $34.00. The company's shares closed last Thursday at $22.29.

According to TipRanks.com, Belanger is a 4-star analyst with an average return of 6.8% and a 47.2% success rate. Belanger covers the Healthcare sector, focusing on stocks such as Amphastar Pharmaceuticals, KalVista Pharmaceuticals, and Verrica Pharmaceuticals.

Collegium Pharmaceutical has an analyst consensus of Strong Buy, with a price target consensus of $35.67.

Collegium Pharmaceutical's market cap is currently $785.7M and has a P/E ratio of 19.60. The company has a Price to Book ratio of 4.71.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Collegium Pharmaceutical, Inc. operates as a pharmaceutical company, which engages in the developing and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR. The Xtampza ER provides pain control while maintaining its extended-release drug release profile after being subjected to common methods of abuse and accidental misuse. The Nucynta ER for the treatment of chronic pain and neuropathic pain associated with diabetic peripheral neuropathy. The Nucynta IR is a release formulation of tapentadol indicated for the management of acute pain severe enough to require an opioid analgesic. The company was founded by Michael Thomas Heffernan in October 2003 and is headquartered in Stoughton, MA.

The post Collegium Pharmaceutical (COLL) Gets a Buy Rating from Needham appeared first on TipRanks Financial Blog.

Source : Tip Ranks More   

What's Your Reaction?

like
0
dislike
0
love
0
funny
0
angry
0
sad
0
wow
0

Next Article

Commercial Metals Company (CMC) Gets a Hold Rating from BMO Capital

In a report released today, David Gagliano from BMO Capital assigned a Hold rating to Commercial Metals Company (CMC – Research Report), with a price target of $32.00. The company's shares closed last Thursday at $30.15. According to TipRanks.com, Gagliano is a 4-star analyst with an average return of 6.8% and a 48.1% success rate. Gagliano covers the Basic Materials sector, focusing on stocks such as United States Steel, Peabody Energy Comm, and Freeport-McMoRan. Currently, the analyst consensus on Commercial Metals Company is a Moderate Sell with an average price target of $30.83, a 2.3% upside from current levels. In a report issued on June 16, J.P. Morgan also initiated coverage with a Hold rating on the stock with a $39.00 price target. See today’s analyst top recommended stocks >> Commercial Metals Company's market cap is currently $3.63B and has a P/E ratio of 11.70. The company has a Price to Book ratio of 1.94. Based on the recent corporate insider activity of 60 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CMC in relation to earlier this year. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities. Commercial Metals Co. engages in the manufacture, recycling, and marketing of steel and metal products. It operates through the following segments: Americas Recycling, Americas Mills, Americas Fabrication, and International Mill. The Americas Recycling segment processes scrap metals for use as a raw material by manufacturers of new metal products. The Americas Mills segment manufactures finished long steel products including reinforcing bar, merchant bar, light structural and other special sections as well as semi-finished billets for re-rolling and forging applications. The Americas Fabrication segment includes rebar fabrication operations, fence post manufacturing facilities, construction-related product facilities and facilities that heat-treat steel to strengthen and provide flexibility. The International Mill segment manufactures rebar, merchant bar and wire rod as well as semi-finished billets. The company was founded by Moses Feldman in 1915 and is headquartered in Irving, TX. The post Commercial Metals Company (CMC) Gets a Hold Rating from BMO Capital appeared first on TipRanks Financial Blog.

In a report released today, David Gagliano from BMO Capital assigned a Hold rating to Commercial Metals Company (CMC – Research Report), with a price target of $32.00. The company's shares closed last Thursday at $30.15.

According to TipRanks.com, Gagliano is a 4-star analyst with an average return of 6.8% and a 48.1% success rate. Gagliano covers the Basic Materials sector, focusing on stocks such as United States Steel, Peabody Energy Comm, and Freeport-McMoRan.

Currently, the analyst consensus on Commercial Metals Company is a Moderate Sell with an average price target of $30.83, a 2.3% upside from current levels. In a report issued on June 16, J.P. Morgan also initiated coverage with a Hold rating on the stock with a $39.00 price target.

Commercial Metals Company's market cap is currently $3.63B and has a P/E ratio of 11.70. The company has a Price to Book ratio of 1.94.

Based on the recent corporate insider activity of 60 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CMC in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Commercial Metals Co. engages in the manufacture, recycling, and marketing of steel and metal products. It operates through the following segments: Americas Recycling, Americas Mills, Americas Fabrication, and International Mill. The Americas Recycling segment processes scrap metals for use as a raw material by manufacturers of new metal products. The Americas Mills segment manufactures finished long steel products including reinforcing bar, merchant bar, light structural and other special sections as well as semi-finished billets for re-rolling and forging applications. The Americas Fabrication segment includes rebar fabrication operations, fence post manufacturing facilities, construction-related product facilities and facilities that heat-treat steel to strengthen and provide flexibility. The International Mill segment manufactures rebar, merchant bar and wire rod as well as semi-finished billets. The company was founded by Moses Feldman in 1915 and is headquartered in Irving, TX.

The post Commercial Metals Company (CMC) Gets a Hold Rating from BMO Capital appeared first on TipRanks Financial Blog.

Source : Tip Ranks More   

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.